DARETABART

UNII:	G3JN6K8LV3
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	DARETABART
GSRS Full Record:	G3JN6K8LV3 i

3011830-62-6
Daretabart
H-gamma1 heavy chain (1-443) [VH Musmus/Homsap (Mus musculus IGHV1-42*04 (86.5%) -(IGHD) -IGHJ4*01 (71.4%) Q120>T (105), G121>Q (106), T122>G (107) /Homo sapiens IGHV1-46*01 (71.9%) -(IGHD) -IGHJ5*01 (75.0%) Q120>T (105), G121>Q (106), T122>G (107), L123>S (108), CDR-IMGT [8.8.6] (26-33.51-58.97-102)) (1-113) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, 5-G1v20 CH2 A105 (CH1 R120 (210) (114-211), hinge 1-15 (212-226), CH2 K105>A (318) (227-336), CH3 E12 (352), M14 (354) (337-441), CHS (442-443)) (114-443)], (216-220')-disulfide with L-kappa light chain (1'-220') [V-KAPPA Musmus/Homsap (Mus musculus IGKV1-110*01 (94.0%) -IGKJ5*01 (100%)/Homo sapiens IGKV2D-29*02 (82.0%) -IGKJ2*01 (81.8%) Q120>A (106'), I126>L (112'), CDR-IMGT [11.3.10] (27'-37'.55'-57'.94'-103')) (1'-113') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')]; dimer (222-222'':225-225'')-bisdisulfide, produced in YB2/0 cell line, glycoform alfa
Immunoglobulin G1 [318-alanine], anti-(human ganglioside GD2) (human-Mus musculus monoclonal RPL001 γ1-chain), disulfide with human-Mus musculus monoclonal RPL001 κ-chain, dimer
daretabart [INN]
immunoglobulin G1-kappa, anti-[Homo sapiens GD2 (disialoganglioside GD2)], monoclonal antibody;

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DARETABART

Synonyms and Mappings

Resources